Just days after Johnson & Johnson (NYSE:JNJ) revealed that it plans to shut down its 410-worker Animas insulin pump subsidiary, Insulet (NSDQ:PODD) said it would offer existing Animas insulin pump users a free trial of the company’s Omnipod system.
Insulet’s Welcome Program includes a free Omnipod tubeless insulin delivery system, built-in blood glucose meter and 30 days of supplies at not cost to the user.
Get the full story at our sister site, Drug Delivery Business News.
The post Insulet looks to lure Animas users appeared first on MassDevice.
from MassDevice http://ift.tt/2kARueg
Cap comentari:
Publica un comentari a l'entrada